Navigation Links
Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
Date:3/16/2009

23,373 General and administrative 3,154 3,501 14,443 12,085 Realized gain on equipment disposal - (105) - (105) Asset impairment - - - - --- --- --- --- Total operating expenses 13,357 10,407 49,157 35,353 ------ ------ ------ ------ Loss from operations (13,357) (10,407) (49,157) (35,353) ------- ------- ------- ------- Other income (expense), net (585) 841 592 2,571 ---- --- --- ----- Net loss (13,942) (9,566) (48,565) (32,782) Preferred stock dividends (125) (125) (500) (500) ---- ---- ---- ---- Loss applicable to common shares $(14,067) $(9,691) $(49,065) $(33,282) ======== ======= ======== ======== Loss per share: Basic and diluted $(0.41) $(0.28) $(1.41) $(1.08) ====== ====== ====== ====== Shares used in calculation of loss per share: Basic and diluted 34,688 34,660 34,686 30,762 ====== ====== ====== ====== Condensed Consolidated Balance Sheets (In thousands) (Unaudited) December 31, 2008 December 31, 2007 ----------------- ----------------- ASSETS: Cash and investment securities $72,755 $92,621 Cash - restricted
'/>"/>
SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... 3, 2015 Report Details What ... areas are going to grow at the fastest rates? ... 2025, assessing data, trends, opportunities and prospects there. ... graphs. Discover the most lucrative areas in the industry ... you assess forecasted sales at overall world market and ...
(Date:9/3/2015)... YORK , Sept. 3, 2015 ... Your New Guide to that Market, its R&D and Sales ... to assess the future of cancer-treating medicines? Visiongain,s new report ... you stay ahead. There you discover financial data, R&D trends, ... In our analysis you see forecasted sales to ...
(Date:9/3/2015)... LONDON, Sept. 3, 2015 With a population ... largest country and therefore also its single largest potential ... years, China has led all major world economies in ... health expenditures, and government health expenditures. As an in ... developed markets of the United States, western European countries, ...
Breaking Medicine Technology:Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 2World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 7IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... the academic partner for the Academy of Integrative Health & Medicine (AIHM) Interprofessional ... the direction of Tieraona Low Dog, MD, an internationally renowned educator, physician and ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... in Patient Experience Conference 2016, to be held April 13-15 at Sheraton Hotel ... hosted event bringing together the collective voices of healthcare leaders, staff, physicians, patients ...
(Date:9/3/2015)... Rhinebeck, NY (PRWEB) , ... September 03, 2015 ... ... Kitslaar when he made the company the final destination of his six-month, 10,000 ... , During the trek—which he calls the “Connecting Las Americas” ...
(Date:9/3/2015)... ... September 03, 2015 , ... BedJet released a new ... v2, for pre-order on Kickstarter. Today the BedJet v2 pre-order campaign blazed ... top 0.1% most successful campaigns ever on crowdfunding giant Kickstarter. , Simple to use ...
(Date:9/3/2015)... ... September 03, 2015 , ... Real Time Pain Relief ... professional bull rider David Mason has signed an official endorsement deal with the company. ... of six and his first bull at 15. He is an Australian bull riding ...
Breaking Medicine News(10 mins):Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 2Health News:Oregon Collaborative for Integrative Medicine Partners with AIHM on First Interprofessional Fellowship 3Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 2Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 3Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 2Health News:Real Time Pain Relief Sponsors the Talented PBR Bull Rider from Down Under - David Mason 3
... ... Geriatrics Association shows a new virtual reality device, the GaitAid, can help stroke patients learn to ... Haifa, Israel (PRWEB) February ... stroke each year. It is one of the leading causes of adult disability in the U.S. ...
... ATLANTA--A new study has found that many male cancer ... radiation therapy have an impaired quality of life and ... , a peer-reviewed journal of the American Cancer Society, ... testosterone deficiency may benefit from testosterone replacement therapy. ...
... , ... ... ... ...
... ... opens it newest location in beautiful Olde Towne Gaithersburg Maryland. Funeral Directors assist ... and multicultural community. , ... Gaithersburg, MD (PRWEB) February 21, 2010 -- A new, affordable option in funeral ...
... three million children have been born as a result of ... tube baby" in 1978. While the majority of these ... at greater risk of certain kinds of birth defects and ... and type 2 diabetes later in life. Carmen Sapienza, ...
... ... Lauderdale, now offers both the Cisco CCNA Security (prerequisite) and Cisco CCSP Certification Courses ... ... as a prerequisite course. These courses may now be taken at the warm ...
Cached Medicine News:Health News:New Successful Treatment Improves Walking Post Stroke 2Health News:WellPoint/Blue Cross Liver Transplant Denial Trial Starts Monday 2Health News:WellPoint/Blue Cross Liver Transplant Denial Trial Starts Monday 3Health News:WellPoint/Blue Cross Liver Transplant Denial Trial Starts Monday 4Health News:WellPoint/Blue Cross Liver Transplant Denial Trial Starts Monday 5Health News:Olde Towne Gaithersburg Welcomes Thibadeau Mortuary - A Lower-Cost Alternative In Funeral and Cremation Service 2Health News:Olde Towne Gaithersburg Welcomes Thibadeau Mortuary - A Lower-Cost Alternative In Funeral and Cremation Service 3Health News:Cisco CCSP Now Requires CCNA Security as Prerequisite 2Health News:Cisco CCSP Now Requires CCNA Security as Prerequisite 3
Used for access and catheterization procedures. Double flexible tipped design permits alternative use of both ends of wire guide depending upon procedural needs. Supplied sterile in peel-open package...
... Coronary Stent System is Guidant's first in ... Cobalt chromium is stronger and more radiopaque ... stent can have similar strength and visibility ... struts that are only .0032" thick. Thinner ...
Stent delivery with extra rail support...
Forte Guide Wire w/Markers: Front line use, 1:1 torque, excellent steering and tracking, sharp vessel images, floppy and moderate support....
Medicine Products: